Blue Cross NC’s third straight year of rate reductions since 2018.
Durham, N.C. – Blue Cross and Blue Shield of North Carolina (Blue Cross NC) will be reducing rates by an average of 1% statewide for 2021 Affordable Care Act (ACA) plans offered to individuals. This is the third straight year that Blue Cross NC has lowered rates—a 3-year total reduction since 2018 of over $380 million.
“We’re pleased to make health insurance more affordable for North Carolinians who buy their own coverage from the individual market,” said Tunde Sotunde, president and CEO of Blue Cross NC. “Our customers can continue to count on us as they navigate challenges during this pandemic and beyond. We will again offer ACA plans in all 100 North Carolina counties, as we have since the beginning of the ACA in 2014.”
The decrease is a result of the company’s efforts to hold down costs while ensuring high-quality health care for members.
2021 rates take into account 2 unexpected and fluid circumstances—the ongoing coronavirus disease 2019 pandemic and customers’ deferral of non-urgent care. After many customers deferred care in March through May, a large number have recently resumed elective procedures, which is reflected in a significant increase in customers’ medical claims for June and July.
Best of Managed Care Cast: Top 5 Episodes From the First Half of 2025
July 18th 2025These interviews are the top episodes, by listens, from among the 21 podcast episodes The American Journal of Managed Care® produced over the first half of 2025. Give them all another listen, and perhaps learn something new.
Read More
From Red Tape to Relief: Rewriting the Rules of Prior Authorization
June 23rd 2025Up to 257 million Americans could benefit from these prior authorization reforms that could have cross-market implications on health care plans administered through commercial insurers, Medicare Advantage, and Medicaid.
Read More
Many Patients Stop GLP-1s Before Reaching Target Dose: Hamlet Gasoyan, PhD
June 19th 2025Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite provider follow-up and efforts to manage side effects, says Hamlet Gasoyan, PhD, Cleveland Clinic.
Read More